Persistent use of nicotine replacement therapy: An analysis of actual purchase patterns in a population based sample

Tobacco Control

Volumn 12, Issue 3, 2003, Pages 310-316

  Shiffman, S ^a,b   Hughes, J R ^c   Pillitteri, J L ^a   Burton, S L ^d  

^a PINNEY ASSOCIATES   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF VERMONT   (United States)

^d GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE GUM;

ADULT; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DRUG MARKETING; FEMALE; HOUSEHOLD; HUMAN; INTERVIEW; MALE; NICOTINE REPLACEMENT THERAPY; POPULATION RESEARCH; SMOKING;

ADMINISTRATION, CUTANEOUS; CHEWING GUM; DRUGS, NON-PRESCRIPTION; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINE; PATIENT ACCEPTANCE OF HEALTH CARE; SMOKING; SMOKING CESSATION;

EID: 0348168402     PISSN: 09644563     EISSN: None     Source Type: Journal    
DOI: 10.1136/tc.12.3.310     Document Type: Article

References (47)

1. Fiore MC, Bailey WC, Cohen SJ, et al. Treating tobacco use and dependence. Clinical Practice Guideline. Rockville, Maryland: US Department of Health and Human Services, Public Health Service, 2000.
2. Hughes JR, Goldstein MG, Hurt RD, et al. Recent advances in the pharmacotherapy of smoking. JAMA 1999;281:72-6.
3. Shiffman S, Gitchell JG, Pinney JM, et al. Public health benefit of over-the-counter nicotine medications. Tobacco Control 1997;6:306-10.
4. Pierce JP, Gilpin EA. Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation. JAMA 2002;288:1260-4.
5. Hughes JR, Shiffman S, Callas P, et al. A meta-analysis of the efficacy of over-the-counter nicotine replacement. Tobacco Control 2003;12:21-7.
6. US Department of Health and Human Services. The health consequences of smoking: nicotine addiction. A report of the Surgeon General, 1988. Rockville, Maryland: Public Health Service, Centers for Disease Control, Office on Smoking and Health, 1988. (DHHS Publication No (CDC) 88-8406.)
7. Murray RP, Bailey WC, Daniels K, et al. Safety of nicotine polacrilex gum used by 3,094 participants in the Lung Health Study. Chest 1996;109:438-45.
8. Henningfield JE. Nicotine medications for smoking cessation. N Engl J Med 1995;333:1196-203.
9. West R, Hajek P, Foulds J, et al. A comparison of the abuse liability and dependence potential of nicotine patch, gum, spray, and inhaler. Psychopharm 2000;149:198-202.
10. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington DC: American Psychiatric Association, 2000.
11. Hajek P, Jackson P, Belcher M. Long-term use of nicotine chewing gum: occurrence, determinants, and effect on weight gain. JAMA 1988;260:1593-6.
12. Hughes JR, Gust SW, Keenan R, et al. Long-term use of nicotine vs. placebo gum. Arch Intern Med 1991;151:1993-8.
13. Johnson RE, Hollis JF, Stevens VJ, et al. Patterns of nicotine gum use in a health maintenance organization. DICP Ann Pharmacother 1991;25:730-5.
14. Hughes JR. Long-term use of nicotine replacement therapy. In: Henningfield JE, Stitzer ML, eds. New developments in nicotine-delivery systems: proceedings of a conference, Johns Hopkins University. Ossining, New York: Cortlandt Communications; 1991:63-7.
15. Hurt RD, Offord KP, Lauger GG, et al. Cessation of long-term nicotine gum use - a prospective, randomized trial. Addiction 1995;90:407-13.
16. Brass EP. Changing the status of drugs from prescription to over-the-counter availability. N Engl J Med 2001;345:810-6.
17. Shiffman S, Hughes JR, Di Marino ME, et al. Patterns of over-the-counter nicotine gum use: persistent use and concurrent smoking. (In press).
18. Shiffman S, Paty JA, Rohay JM, et al. The efficacy of computer-tailored smoking cessation material as a supplement to polacrilex nicotine gum treatment. Arch Intern Med 2000;160:1675-81.
19. Greenberg K. Using panels to understand the consumer. Consumer Insight 2002;4:16-18, 28.
20. Centers for Disease Control. Cigarette smoking among adults - United States, 1998. MMWR Morb Mortal Wkly Rep 2000;49:881-4.
21. US Census Bureau. Profile of general demographic characteristics: 2000 (table DP-1). URL: http://factfinder.census.gov/servlet/ QTTable?ds_name= D&geo_id=D&qr_name=DEC_2000_SF1 _U_DP1&_lang=en.
22. National Center for Health Statistics. Data from the National Health Interview Survey. Hyattsville, Maryland: Public Health Service, 2000.
23. Woods JH, Katz JL, Winger G. Abuse liability of benzodiazepines. Pharmacol Rev 1987;39:251-414.
24. Shiffman S, Rolf CN, Hellebusch SJ, et al. Real-world efficacy of prescription and over-the-counter nicotine replacement therapy. Addiction 2002;97:505-16.
25. Schauffler HH, Parkinson MD. Health insurance coverage for smoking cessation services. Health Educ Q 1993;20:185-206.
26. Piasecki TM, Fiore MC, Baker TB. Profiles in discouragement: two studies of variability in the time course of smoking withdrawal symptoms. J Abnormal Psych 1998;2:238-51.
27. Garvey AJ, Bliss RE, Hitchcock JL, et al. Predictors of smoking relapse among self-quitters: a report from the Normative Aging Study. Addict Behav 1992;17:367-77.
28. Hughes JR, Pillitteri JL, Callas PW, et al. Misuse of and dependence on over-the-counter nicotine gum in a volunteer sample. (In press).
29. Benowitz NL. Pharmacokinetic considerations in understanding nicotine dependence. In: The biology of nicotine dependence. Wiley, Chichester (Ciba Foundation Symposium 152), 1990:186-209.
30. Benowitz NL. Clinical pharmacology of inhaled drugs of abuse: implications in understanding nicotine dependence. In: Chiang CN, Hawks RL, eds. Research findings on smoking of abused substances. National Institute on Drug Abuse Research Monograph 99. Rockville, Maryland: US Department of Health and Human Services, Public Health Service; 1990:12-29.28.
31. Benowitz NL, Prochet H, Sheiner L, et al. Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum. Clin Pharmacol Ther 1988;44:23-8.
32. Fant RV, Henningfield JE, Shiffman S, et al. A pharmacokinetic crossover study to compare the absorption characteristics of three transdermal nicotine patches. Pharm Biochem Behav 2000;67:479-82.
33. Gorsline J. Nicotine pharmacokinetics of four nicotine transdermal systems. Health Values 1993;17:20-4.
34. Henningfield JE, Keenan RM. Nicotine delivery kinetics and abuse liability. J Consult Clin Psych 1993;61:743-50.
35. Nemeth-Coslett R, Henningfield JE, O'Keefe MK, et al. Nicotine gum: dose-related effects on cigarette smoking and subjective ratings. Psychopharmacol 1987;92:424-30.
36. Stitzer ML, De Wit H. Abuse liability of nicotine. In: Benowitz NL, ed. Nicotine safety and toxicity. New York: Oxford University Press; 1998:119-31.
37. Hughes JR. Why does smoking so often produce dependence? A somewhat different view. Tobacco Control 2001;10:62-4.
38. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research: principles and quantitative methods. New York: Van Nostrand Reinhold, 1982:120-3.
39. Tofani L. Hooked on an addiction fighter. The Philadelphia Inquirer, 28 March 2000:A1.
40. Trubo R. Addicted to Nicorette®. WebMD Medical News. URL: http://my.webmd.com/content/article/1685.53191
41. Wu J. Channel 7 news at noon. WHDH-W News. Boston: National Broadcasting Corporation. 18 September 2000.
42. Carpenter MJ, Hughes JR, Solomon LJ, et al. Smoking reduction and motivational advice increase future cessation among smokers not currently planning to quit. J Consult Clin Psych. (In press).
43. Benowitz NL. Nicotine replacement therapy: What has been accomplished - can we do better? Drugs 1993;45:157-70.
44. West RJ, Russell MAH. Dependence on nicotine chewing gum. JAMA 1986;256:3215.
45. Etter JF, Perneger TV. Attitudes toward nicotine replacement therapy in smokers and ex-smokers in the general public. Clin Pharmacol Ther 2001;69:175-83.
46. Benowitz NL, Gourlay SG. Cardiovascular toxicity of nicotine: Implications for nicotine replacement therapy. J Am Coll Cardiol 1997;29:1422-31.
47. Joseph AM, Norman SM, Ferry LH, et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med 1996;335:1792-8.